Growing geriatric population, rising prevalence of eye disorders such as retinal detachment and diabetic retinopathy, increasing patient preference for minimally invasive surgeries are key factors contributing to high CAGR of Retinal Surgery Devices during the forecast period.

The global Retinal Surgery Devices market was valued at USD 2,082.2 Million in 2020 and is expected to reach USD 3,776.9 Million by the year 2028, at a CAGR of 7.7%. The major factors driving the growth of the retinal surgery devices market during the forecast years are the rising technological advancements and the growing number of applications of surgical devices. Moreover, the ever-increasing geriatric population and the rising prevalence of eye-related retinal disorders are anticipated to accelerate the growth of the global market in the forecast period. The emerging economies worldwide are projected to offer potential growth opportunities for the market further. Low compliance rate and non-adherence to therapeutic approaches that are formulated to reduce vision loss risk in diabetic retinopathy are also expected to shift the focus towards surgical devices, thereby fueling the market growth. Non-compliance with the vision care guidelines by the patients is recognized as a complex health issue. According to research conducted by NCBI, one-third of the diabetic patients were found to be unsuccessful in following the vision care guidelines in the United States. Also, in emerging economies such as China & India, the non-adherence proportion exceeds 60%.

Key companies profiled in the report include

Alcon, Bausch & Lomb Incorporated, Carl Zeiss, Topcon Corporation, Synergetics, IRIDEX Corporation, Ellex Medical Lasers, Escalon Medicals, Second Sigh Medical Products, and Erbe Elektromedizin

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2255

The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Retinal Surgery Devices market.

The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.

The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.

The key geographical regions analyzed in the market report are:

• North America (U.S.A., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Order this Report @ https://www.reportsanddata.com/report-pricing/2255

Retinal Surgery Devices Market Segmentation based on Types:

Product (Revenue, USD Million; 2018–2028)

• Vitrectomy Machines
• Vitrectomy Packs
• Surgical Instruments
• Microscopic Illumination Equipment
• Retinal Laser Equipment
  • Photocoagulation Devices
  • Photodisruption Devices
  • SLT
• Others

Application (Revenue, USD Million; 2018–2028)

• Diabetic Retinopathy
• Retinal Detachment
• Epiretinal Membrane
• Macular Hole
• Others

End Use (Revenue, USD Million; 2018–2028)

• Hospital and Clinics
• Ambulatory Services
• Ophthalmology Centers
• Others

Salient Trends of the Retinal Surgery Devices Market

• The involvement of government organizations in formulating recommendations and guidelines along with tracking its proper implementation for efficient management is a major factor supporting the adoption of retinal surgery devices. For instance, in April 2018, The U.S. Food and Drug Administration permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.
• The growing trend of utilizing PHACO machines along with vitrectomy machines to combine the retinal and cataract procedures is projected to accelerate the growth of the retinal surgery devices market.
• The unaddressed need and high clinical urgency to incorporate retinal surgery devices, thereby, presents lucrative growth opportunities for the market
• Embryology is an exciting tool in retinal recovery, mainly with the use of stem cells. For instance, Holoclar is currently the only clinically approved stem cell treatment for the eye.
• Diabetic retinopathy is one of the major complications induced in diabetes. As a result of which, increasing diabetic population base is anticipated to be one of the impact rendering growth drivers for retinal surgery devices market during the forecast period. According to the National Diabetes Statistics Report one of ten is suffering from diabetes which is nearly 9.4% of the total U.S population
• Considering the clinical condition, according to American Academy of Ophthalmology, Diabetic retinopathy affects nearly 7.7 million Americans age 40 and older. The number of people in the United States with diabetes is increasing rapidly and it is expected to rise further. More than 29 million Americans have diabetes

Request For customization @ https://www.reportsanddata.com/request-customization-form/2255

Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.

Browse More Report:

Biosurgery Market @ https://www.biospace.com/article/biosurgery-market-growth-2022-2028-rising-demand-for-biosurgery-for-prevention-of-blood-loss-during-surgeries/

Acute Lymphoblastic Leukemia Drug Market @ https://www.biospace.com/article/acute-lymphoblastic-leukemia-drug-market-size-2022-2028-increasing-adoption-of-western-lifestyles-including-dietary-modifications-and-sedentary-lives/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com